4-chloro-N1-(3-methylbenzyl)-N3-phenylisophthalamide

ID: ALA5287514

Max Phase: Preclinical

Molecular Formula: C22H19ClN2O2

Molecular Weight: 378.86

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1cccc(CNC(=O)c2ccc(Cl)c(C(=O)Nc3ccccc3)c2)c1

Standard InChI:  InChI=1S/C22H19ClN2O2/c1-15-6-5-7-16(12-15)14-24-21(26)17-10-11-20(23)19(13-17)22(27)25-18-8-3-2-4-9-18/h2-13H,14H2,1H3,(H,24,26)(H,25,27)

Standard InChI Key:  QJGUAEWTHPWKAH-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
   -2.1425    1.0334    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1425    0.2084    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4280   -0.2041    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4280   -1.0327    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1425   -1.4452    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -0.7115   -1.4408    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0013   -1.0290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0013   -0.2037    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7131    0.2087    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4276   -0.2037    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1421    0.2087    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8566   -0.2037    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8566   -1.0322    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5731   -1.4404    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2833   -1.0285    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2833   -0.2033    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5712    0.2086    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9977    0.2091    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7131    1.0338    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7133    0.2082    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8569   -0.2041    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5715    0.2084    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2814   -0.2033    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9977    0.2047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9977    1.0329    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2833    1.4452    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5715    1.0334    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  4  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 12  2  0
 16 18  1  0
  9 19  2  0
  8 20  1  0
 20  3  2  0
 21  2  1  0
 22 21  1  0
 23 22  1  0
 24 23  2  0
 25 24  1  0
 26 25  2  0
 22 27  2  0
 27 26  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5287514

    ---

Associated Targets(Human)

PPARG Tclin Peroxisome proliferator-activated receptor gamma (15191 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 378.86Molecular Weight (Monoisotopic): 378.1135AlogP: 4.83#Rotatable Bonds: 5
Polar Surface Area: 58.20Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 13.98CX Basic pKa: CX LogP: 4.98CX LogD: 4.98
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.67Np Likeness Score: -1.73

References

1. Orsi DL, Ferrara SJ, Siegel S, Friberg A, Bouché L, Pook E, Lienau P, Bluck JP, Lemke CT, Akcay G, Stellfeld T, Meyer H, Pütter V, Holton SJ, Korr D, Jerchel-Furau I, Pantelidou C, Strathdee CA, Meyerson M, Eis K, Goldstein JT..  (2023)  Discovery and characterization of orally bioavailable 4-chloro-6-fluoroisophthalamides as covalent PPARG inverse-agonists.,  78  [PMID:36542958] [10.1016/j.bmc.2022.117130]

Source